NVO

Novo Nordisk A/S $43.07 1M -7.2% 3M -2.0% YTD -17.8% as of 2026-09-11
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  · earnings beat miss  ·  ring before open after close  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.0%
Next 1 week
+0.3%
Next 1 month
-0.4%
Seasonality
Mildly positive window
Next 30 days (to Oct 14): +0.9% median, 57% of the last 44 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 3
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.07%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.12 -0.2% · Seasonal tilt -0.2%
$191.9B market cap (#17 US) $496M/day volume 46% volatility -21% 1-year -71% from ATH
52-week range · 27% of the way up · -33% from the high
$35.12$64.16

Congressional trades in NVO Full tracker →

15 members · 19 buys / 15 sells · $452K–$1.3M disclosed · latest filing Jul 21, 2026.

BUY AA Alan Armstrong · traded Mar 30, 2026 $15K–$50K
SELL LM Lisa McClain · traded Oct 31, 2025 $1K–$15K
SELL LM Lisa McClain · traded Oct 30, 2025 $1K–$15K
BUY LM Lisa McClain · traded Oct 30, 2025 $1K–$15K
BUY LM Lisa McClain · traded Sep 11, 2025 $1K–$15K
BUY MG Marjorie Taylor Greene · traded Oct 15, 2025 $1K–$15K
BUY VH Valerie Hoyle · traded Oct 29, 2024 $1K–$15K
SELL LM Lisa McClain · traded Aug 4, 2025 $1K–$15K

Earnings Full history →

Next report 2026-11-04 (Wednesday, before open, in 51 days) · EPS est. 5.11.

1-day std dev
5.1%
Finished up
44%
Biggest pop
+8.3%
Biggest drop
-12.9%

Standard deviation of the close-to-close move over the last 45 reports. History, not a forecast.

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.